» Articles » PMID: 28551328

Association of Expression of the Hedgehog Signal with Merkel Cell Polyomavirus Infection and Prognosis of Merkel Cell Carcinoma

Overview
Journal Hum Pathol
Specialty Pathology
Date 2017 May 29
PMID 28551328
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer that mostly occurs in the elderly. Merkel cell polyomavirus (MCPyV) is detected in approximately 80% of MCCs and is associated with carcinogenesis. Hedgehog signaling pathway plays a role in human embryogenesis and organogenesis. In addition, reactivation of this pathway later in life can cause tumors. Twenty-nineMCPyV-positive and 21 MCPyV-negative MCCs were immunohistochemically stained with primary antibodies for hedgehog signaling (SHH, IHH, PTCH1, SMO, GLI1, GLI2, and GLI3) and evaluated using H-score. Polymerase chain reaction and sequence analysis for SHH and GLI1 exons were also performed. Expression of SHH was higher in MCPyV-positive MCCs than in MCPyV-negative MCCs (P<.001). Higher expression of GLI1, MCPyV infection, male sex, and Japanese ethnicity were associated with better overall survival (P=.034, P=.001, P=.042, and P=.036, respectively). Higher expression of SHH and MCPyV infection were associated with improved MCC-specific survival (P=.037 and P=.002, respectively). The mutation analysis of prognosis-related GLI1 and SHH genes in our study revealed a low frequency of mutations in the 10 exons examined, except GLI1 exon 5 (18/22 cases), all having the same silent mutation of c.576G>A. Only 2 mutations with amino acid changes were detected in MCPyV-negative MCCs only: 1 missense mutation in GLI1 exon 4 and 1 nonsense mutation in SHH-3B. Expression of SHH and GLI1 may be useful prognostic markers of MCC because increased expression was associated with better prognosis. The high rate of c.576G>A silent mutation in GLI1 exon 5 was a feature of MCC.

Citing Articles

The Emerging Role of Hedgehog Signaling in Viral Infections.

Zhou Y, Huang J, Jin B, He S, Dang Y, Zhao T Front Microbiol. 2022; 13:870316.

PMID: 35464958 PMC: 9023792. DOI: 10.3389/fmicb.2022.870316.


Merkel cell polyomavirus-negative Merkel cell carcinoma is associated with JAK-STAT and MEK-ERK pathway activation.

Iwasaki T, Hayashi K, Matsushita M, Nonaka D, Kohashi K, Kuwamoto S Cancer Sci. 2021; 113(1):251-260.

PMID: 34724284 PMC: 8748213. DOI: 10.1111/cas.15187.


When Viruses Cross Developmental Pathways.

Trivedi P, Patel S, Bellavia D, Messina E, Palermo R, Ceccarelli S Front Cell Dev Biol. 2021; 9:691644.

PMID: 34422814 PMC: 8375270. DOI: 10.3389/fcell.2021.691644.


Merkel Cell Carcinoma from Molecular Pathology to Novel Therapies.

Stachyra K, Dudzisz-Sledz M, Bylina E, Szumera-Cieckiewicz A, Spalek M, Bartnik E Int J Mol Sci. 2021; 22(12).

PMID: 34208339 PMC: 8231245. DOI: 10.3390/ijms22126305.


Molecular Profiling of Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma and Cutaneous Melanoma.

Mokanszki A, Mehes G, Csoma S, Kollar S, Chien Y Diagnostics (Basel). 2021; 11(2).

PMID: 33535453 PMC: 7912722. DOI: 10.3390/diagnostics11020212.